These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36226491)

  • 1. Influence of bisphosphonates or recombinant human parathyroid hormone on
    De Winter DTC; Van Atteveld JE; Buijs-Gladiness JGCAM; Pieters R; Neggers SJCMM; Meijerink JPP; Van den Heuvel-Eibrink MM
    Haematologica; 2023 Feb; 108(2):605-609. PubMed ID: 36226491
    [No Abstract]   [Full Text] [Related]  

  • 2. Bones, groans and blasts.
    Shanks D; Linke R; Saxon B
    J Paediatr Child Health; 2001 Oct; 37(5):504-6. PubMed ID: 11885718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood aleukemic leukemia with hypercalcemia and bone lesions mimicking metabolic bone disease.
    Ganesan P; Thulkar S; Gupta R; Bakhshi S
    J Pediatr Endocrinol Metab; 2009 May; 22(5):463-7. PubMed ID: 19618667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?
    Amin NL; James RM; Phillips R
    Arch Dis Child; 2016 Mar; 101(3):287-90. PubMed ID: 26768828
    [No Abstract]   [Full Text] [Related]  

  • 5. Avascular necrosis of bone in leukemia and osteonecrosis of jaw by bisphosphonates.
    Nastro E; Allegra A; Oteri G; Ferlito S; Alonci A; Bellomo G; D'Angelo A; Tolomeo A; Cicciù D; De Ponte FS; Musolino C
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2701-3. PubMed ID: 19926001
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute lymphoblastic leukemia accompanied by severe hypercalcemia; successful treatment with bisphosphonate].
    Ogihara T; Kikuchi Y; Imai Y; Ohsaka A; Isaka M; Oka Y
    Rinsho Ketsueki; 1995 Jan; 36(1):29-34. PubMed ID: 7715075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.
    Barr RD; Guo CY; Wiernikowski J; Webber C; Wright M; Atkinson S
    Med Pediatr Oncol; 2002 Jul; 39(1):44-6. PubMed ID: 12116079
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercalcemia with nephrocalcinosis and impaired renal function due to increased Parathyroid hormone secretion at onset of childhood acute lymphoblastic leukemia.
    Lankisch P; Kramm CM; Hermsen D; Wessalowski R
    Leuk Lymphoma; 2004 Aug; 45(8):1695-7. PubMed ID: 15370228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
    Shen L; Xie X; Su Y; Luo C; Zhang C; Zeng B
    PLoS One; 2011; 6(10):e26267. PubMed ID: 22022584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates.
    Bonjour JP; Troehler U; Preston C; Fleisch H
    Am J Physiol; 1978 Jun; 234(6):F497-505. PubMed ID: 208419
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
    Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
    Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curing acute lymphoblastic leukemia and avoiding osteonecrosis: can't we have it all?
    Ducassou S; Pérel Y
    Pediatr Blood Cancer; 2013 May; 60(5):713-4. PubMed ID: 23335158
    [No Abstract]   [Full Text] [Related]  

  • 14. Common acute lymphoblastic leukemia preceded by hypercalcemia in an infant.
    Ohoishi S; Koshibu T; Kazama H; Shinomiya N; Aoki T
    Acta Paediatr Jpn; 1996 Oct; 38(5):549-52. PubMed ID: 8942021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of osteoporosis in men.
    Orwoll ES
    Calcif Tissue Int; 2004 Aug; 75(2):114-9. PubMed ID: 15383924
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia.
    Atkinson SA; Fraher L; Gundberg CM; Andrew M; Pai M; Barr RD
    J Pediatr; 1989 May; 114(5):793-800. PubMed ID: 2785592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for treatment of childhood hypercalcemia.
    Lteif AN; Zimmerman D
    Pediatrics; 1998 Oct; 102(4 Pt 1):990-3. PubMed ID: 9755274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein.
    Harutsumi M; Akazai A; Kitamura T; Manki A; Tanaka H; Oda M; Seino Y
    Miner Electrolyte Metab; 1995; 21(1-3):171-6. PubMed ID: 7565443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
    Yu X; Schøller J; Foged NT
    Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models.
    Janke LJ; Kim J; Payton MA; Jenkins DA; Cai X; Finch ER; Liu Y; Relling MV; Karol SE
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29183. PubMed ID: 34121318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.